Warberg Asset Management LLC Medicenna Therapeutics Corp. Transaction History

Warberg Asset Management LLC

  • $12.6 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023
BUY
$0.28 - $0.51 $2,800 - $5,100
10,000 Added 100.0%
20,000 $6,000
Q1 2023

May 15, 2023
SELL
$0.5 - $0.78 $5,000 - $7,800
-10,000 Reduced 50.0%
10,000 $6,000
Q4 2022

Feb 13, 2023
SELL
$0.4 - $0.68 $3,800 - $6,460
-9,500 Reduced 32.2%
20,000 $9,000
Q3 2022

Nov 07, 2022
BUY
$0.83 - $1.78 $24,485 - $52,510
29,500 New
29,500 $24,000

Others Institutions Holding MDNA

# of Institutions
3
Shares Held
863K
Call Options Held
0
Put Options Held
0
View Full List

About Medicenna Therapeutics Corp.

MDNA Quotes by TradingView
  • Ticker MDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,637,504
  • Market Cap $21.6M
  • Description
  • Medicenna Therapeutics Corp., an immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases. Its lead product is MDNA55, an interleukin- 4 (IL-4) EC that has completed Phase IIb clinical trial for the treatment of recurrent glioblastoma, as well as...
More about MDNA
Track This Portfolio

Track Warberg Asset Management LLC Portfolio

Follow Warberg Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Warberg Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Warberg Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email